Bought
Maintained
Sold
Other funds holding ACLS
RP
Aviva's ACLS Position: Q2 2026 in Review
Aviva sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 5,308 shares — an estimated $494K sold.
Aviva first reported a position in ACLS in Q4 2021 and held it in 15 quarters. The position peaked at $2.05M in Q4 2021. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Aviva reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
- Aviva sold 5,308 Axcelis shares in Q2 2026, an estimated $494K.
- Aviva first reported a position in Axcelis in Q4 2021 and held it in 15 quarters.
- Aviva's Axcelis position peaked at $2.05M in Q4 2021.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.